Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 10,993-11,004 of 23,847
Device study icon
UnknownNCT06299787

Cognitive Dysfunction in the Addictions Study - Project 4 (P4)

This study is looking at whether intermittent theta burst stimulation can help people with depression or Addiction. Participants take part in intermittent theta burst stimulation and complete follow-up assessments.

In Toronto
Addiction, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 59 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Addiction, Depression
Behavioral study icon
CompletedNCT06661616

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Paris
Depression, BipolarityOtherOver 18 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression, Bipolarity
Drug study icon
OngoingEUCTR 2021-001333-38

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

This study is looking at whether BRINTELLIX can help people with Early schizophrenia. Participants receive the study medicine BRINTELLIX and complete study visits and assessments.

In Spain
SchizophreniaOther
Countries
Spain
Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Condition
Schizophrenia
Drug study icon
CompletedNCT03671525

Cognitive Effects of Nimodipine in people with Schizophrenia

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Baltimore
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06155786

Cognitive Effects of tDCS and tRNS in Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Tehran
SchizophreniaBehavioralFrom 18 Years to 50 Years
Countries
Iran
Sponsor
The National Brain Mapping Laboratory (NBML)
Condition
Schizophrenia
Drug study icon
CompletedNCT00597896

Cognitive Enhancement in Bipolarity

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Glen Oaks
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwell Health
Condition
Bipolarity
Behavioral study icon
CompletedNCT05400512

Cognitive Enhancement in Depression (The COG-D Study)

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville
DepressionBehavioralOver 60 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Depression
Behavioral study icon
CompletedNCT03872310

Cognitive Enhancement on Working Memory in people with Schizophrenia

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Taipei
SchizophreniaBehavioralFrom 20 Years to 55 Years
Countries
Taiwan
Sponsor
Taipei Medical University Shuang Ho Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00167362

Cognitive Enhancement Therapy for Early-Stage Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh
SchizophreniaBehavioralFrom 16 Years to 51 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.